Qualigen Therapeutics Inc

NASDAQ:QLGN  
3.42
-0.10 (-2.84%)
3:59:53 PM EDT: $3.42 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Qualigen Therapeutics Inc Stock, NASDAQ:QLGN

5857 Owens Avenue, Suite 300, Carlsbad, California 92008
United States of America
Phone: +1.760.452.8111
Number of Employees: 4

Description

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.